The current valuation score of Altimmune Inc is 7.38, ranking 238 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.18, which is -56.10% below the recent high of -1.40 and -193.39% above the recent low of -9.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.